Skip to main
BLLN

Billiontoone Inc (BLLN) Stock Forecast & Price Target

Billiontoone Inc (BLLN) Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

BillionToOne is well-positioned to capitalize on the potential expansion of guidelines and demand for genetic testing in both prenatal and oncology markets. The company's strong technology platform and innovative products, coupled with its plans to disrupt traditional carrier screening, will drive future revenue growth and high margins. In addition, their successful investor dinner, new payor contracts, and expanding market share in the NIPT market indicate promising financial prospects.

Bears say

BillionToOne is facing challenges and a negative outlook due to their slow revenue growth, decreasing testing volume, and high operating expenses, which have resulted in lower profit margins. Additionally, the company faces competition in both the prenatal and oncology markets and has yet to fully penetrate these markets. There are also potential risks related to the company's technology platform and limitations in the markets they are targeting. While the company has achieved profitability in its first few years, it will need to address these challenges and maintain strong financials to sustain long term success.

Billiontoone Inc (BLLN) has been analyzed by 8 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Billiontoone Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Billiontoone Inc (BLLN) Forecast

Analysts have given Billiontoone Inc (BLLN) a Buy based on their latest research and market trends.

According to 8 analysts, Billiontoone Inc (BLLN) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $125.88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $125.88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Billiontoone Inc (BLLN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.